September 05, 2025
The Second Circuit on Friday affirmed a former Pfizer Inc. statistician's insider trading conviction for making $272,000 in options trades from nonpublic news about the success of trials for the COVID-19 therapy drug Paxlovid, rejecting his arguments that prosecutors improperly shifted their legal theory at trial and pursued the case in the wrong venue.
August 06, 2024
A Manhattan federal judge sentenced a former Pfizer Inc. statistician from New Jersey to nine months in prison Tuesday after a jury convicted him of insider trading on secrets about his former company's COVID-19 therapy trials for an illegal $272,000 profit.
July 15, 2024
A former Pfizer employee argued that he shouldn't go to prison after a Manhattan federal jury convicted him of insider trading over clinical trial results for the drug Paxlovid, pointing out that a friend of his and co-defendant had dodged a custodial sentence in the case after helping prosecutors.
April 12, 2024
An electrical engineer was sentenced to probation Friday for trading Pfizer Inc.'s stock using confidential tips about the efficacy of its COVID-19 drug, after a Manhattan federal court recognized his decision to voluntarily assist prosecutors with the trial conviction of his friend, a former Pfizer employee who leaked insider information.
January 18, 2024
A former Pfizer employee was convicted by a Manhattan federal jury Thursday of trading on inside information about the company's COVID-19 drug Paxlovid.
January 17, 2024
A former Pfizer employee's failure to conceal his profitable trading related to the company's COVID-19 drug Paxlovid was "stupid," not exculpatory as his lawyers have claimed, a Manhattan federal prosecutor said Wednesday at the close of trial.
January 10, 2024
A former Pfizer employee accused of insider trading "gambled on options all the time," his attorney told a Manhattan federal jury on Wednesday, pointing to what he called a "giant hole" in the criminal case.
October 27, 2023
Prosecutors have told a Manhattan federal judge that data seized from a cellphone belonging to a former Pfizer employee they accuse of leaking clinical trial data for insider-trading purposes should be admissible in the fraud case.
October 19, 2023
A California man pled guilty in Manhattan federal court Thursday to trading on insider information about a trial of Pfizer's COVID-19 medicine Paxlovid.
September 29, 2023
A former Pfizer Inc. statistician and a computer engineer accused of trading on secret information about the company's Paxlovid COVID-19 therapy trials urged a Manhattan federal judge to suppress evidence the government obtained through search warrants they say contained "false and misleading" information.